1
Background : The N-methyl-D-aspartate receptor antagonist, ketamine, produces a clinical syndrome of thought
disorder, perceptual distortion, and cognitive impairment.
Methods : We have administered ketamine to healthy
volunteers to characterize the formal thought disorder and
specific memory dysfunction associated with ketamine.
Ten healthy volunteers underwent a double-blind, placebo-controlled, ketamine infusion (0.12 mg/kg bolus and
0.65 mg/kg/hour). Thought disorder was evaluated with
the Scale for the Assessment of Thought, Language and
Communication. Cognitive testing involved working and
semantic memory tasks.
Results : Ketamine produced a formal thought disorder, as
well as impairments in working and semantic memory. The
degree of ketamine-induced thought disorder significantly
correlated with ketamine-induced decreases in working
memory and did not correlate with ketamine-induced
impairments in semantic memory.
Conclusions : This study characterizes the formal thought
disorder associated with ketamine and may suggest that
ketamine-induced deficits in working memory are associated with ketamine-induced thought disorder. Biol Psychiatry 1998;43:811–816 Published 1998 Society of Biological Psychiatry
En vous souhaitant une bonne lecture
ketaminmemory.pdf
Dernière modification par Sociophrenic (27 janvier 2023 à 06:30)
Hors ligne
1
[ Forum ] Première fois - Kétamine, troubles psychiques, dosage et co...
|
3 | |
[ Forum ] Effets secondaires - Actualités ketamine et troubles somatiques associés
|
0 | |
[ Forum ] Etude - Kétamine et eskétamine dans le traitement des troubles dépressifs
|
4 | |
[ PsychoWIKI ] Kétamine, effets, risques, témoignages |